MedPath

iLab Co., Ltd

πŸ‡°πŸ‡·South Korea
Ownership
Holding
Employees
-
Market Cap
-
Website
http://www.ilab.co.kr

Clinical Trials

4

Active:0
Completed:1

Trial Phases

1 Phases

Phase 1:4

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (4 trials with phase data)β€’ Click on a phase to view related trials

Phase 1
4 (100.0%)

MAD Study of IA-14069

Phase 1
Recruiting
Conditions
Healthy
Rheumatoid Arthritis
Interventions
First Posted Date
2022-09-09
Last Posted Date
2025-05-20
Lead Sponsor
ILAb Co., Ltd.
Target Recruit Count
75
Registration Number
NCT05533372
Locations
πŸ‡ΊπŸ‡Έ

ICON plc., Lenexa, Kansas, United States

SAD Study of IA-14069

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Placebo
First Posted Date
2022-04-08
Last Posted Date
2023-01-04
Lead Sponsor
ILAb Co., Ltd.
Target Recruit Count
40
Registration Number
NCT05317741
Locations
πŸ‡ΊπŸ‡Έ

ICON plc., Lenexa, Kansas, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.